CPhI Voices The Combined Opinion Of Over 100,000 Attendees Globally And Will Continue To Do So

CPhI India and its co-located event P-MEC, are one of the largest events for the pharma sector in South Asia. This year, CPhI & P-MEC India has a new address: India Expo Centre, New Delhi. Yogesh Mudras, Managing Director, UBM India divulges more details on this year’s editions of these events, their key highlights and the impact they intend to create, in an exclusive interaction with Lakshmipriya Nair

- Lakshmipriya Nair

How will CPhI 2018 differ from its previous editions?

With every edition of CPhI, we succeed in bringing about an unparalleled thought leadership, community building and knowledge sharing experience that stands out from any other fair. Consistently every year, we are keen to push the national agenda forward and break new frontiers, while offering our attendees the much celebrated features. By organising such a signature show in India, the CPhI-PMEC under the aegis of the India Pharma Week (IPW) firmly establishes the country as an impressive hub and global destination for the sector.

Within the realm of the IPW, the CEO Round table stands out as one of the most distinguished and successful events. For the last two years, the exclusive, closed-door CEO Round table has been eminently successful as a strategic gathering of CEOs of the nation’s leading pharma companies who deep dive into thought-provoking discussions on subjects. The recommendations from elite thought leaders results in a White Paper Report that is presented to policy makers and the power corridors of the nation.

This year, we move forward the country’s agenda of making India an uncontested Pharma Supergiant for the first time, to international shores, at CPhI Worldwide, in Madrid where eminent CEOs from the industry will participate in Discussion 1: ‘The Global Perspective’. This will subsequently be followed by Discussion 2: ‘National Perspective’ at the India Pharma Week in Greater Noida. Both the discussions will form an integral part of the 3rd edition of the CEO Round table.